EpiPen Maker Mylan Settles For $485 Million In Medicaid Dispute
The federal Medicaid program had accused Mylan of underpaying required rebates for the EpiPen, which is used to reverse serious allergic reactions. The company said it committed no wrongdoing.
Read more on NPR
October 8, 2016 at 05:33AM
Health Care
Thứ Bảy, 8 tháng 10, 2016
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét